Effect of an early invasive strategy based on time of symptom onset in patients with non-ST elevation myocardial infarction. (3rd October 2022)

• Record Type: Journal Article
• Authors: Bae, S A; Cha, J J; Kim, S W; Lim, S; Kim, J H; Joo, H J; Park, J H; Park, S M; Hong, S J; Yu, C W; Lim, D S; Jeong, M H; Ahn, T H
• Is Part Of: European heart journal. Volume 43(2022)Supplement 2
• Publication Date: 2022-10-03
• Subjects: Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; 616.12005
• DOI: 10.1093/eurheartj/ehac544.1200
• Languages: English
• ISSNs: 0195-668X

Abstract

Abstract: Background: A limitation of the current guidelines of the timing of invasive coronary angiography (ICA) for patients with non-ST-segment elevation (NSTE) acute coronary syndrome is based on randomization time. So far, no study has reported the clinical outcomes of invasive strategy timing based on the time of symptom onset. Herein, we aimed to investigate the effect of invasive strategy timing from the time of symptom onset on the 3-year clinical outcomes of patients with NSTE myocardial infarction (MI). Methods and results: Among 13, 104 patients from the Korea Acute Myocardial Infarction Registry-National Institutes of Health, we evaluated 5, 856 patients with NSTEMI. The patients were categorized according to symptom-to-catheter (StC) time (<48 h and ≥48 h). The primary outcome was 3-year all-cause mortality, and the secondary outcome was a 3-year composite of all-cause mortality, recurrent MI, and hospitalization for heart failure. Overall, 3, 919 (66.9%) patients were classified into the StC time <48 h group. This group had lower all-cause mortality than the StC time ≥48 h group (7.3% vs. 13.4%, p<0.001). The continuous association of StC time and risk of primary and secondary endpoints showed shorter StC time (reference: 48 h), and lower adjusted hazard ratio reduction was observed. In multivariable analysis, independent predictors of delayed ICA were older age, non-specific symptoms, no use of emergency medical services, no ST-segment deviation, chronic kidney disease, and Global Registry of Acute Coronary Events score >140. Conclusion: Early invasive strategy based on the StC time improves all-cause mortality in patients with NSTEMI. Funding Acknowledgement: Type of funding sources: None.